Compound Detail
CHEMBL4298086
POZELIMAB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL4298086 |
| Name | POZELIMAB |
| Phase | Approved |
| Structure Type | SEQ |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
5
Known Names
4
Indications
1
Mechanisms
Drug Information
| Molecule Type | Antibody |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Complement C5 inhibitor | INHIBITOR | Complement C5 | ✓ | ✓ |
Indications
Protein-Losing Enteropathies Hemoglobinuria Myasthenia Gravis Hemoglobinuria, Paroxysmal
ATC Classification
L04AJ11
pozelimab
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSUPPRESSANTS
Drug Warnings
Black Box Warning
infectious disease
Black Box Warning
neurotoxicity
Data from ChEMBL 36 via Core Engine